Literature DB >> 22462736

Angiotensin peptides and nitric oxide in cardiovascular disease.

Kaushik P Patel1, Harold D Schultz.   

Abstract

SIGNIFICANCE: The renin-angiotensin system (RAS) plays an important role in the normal control of cardiovascular and renal function in the healthy state and is a contributing factor in the development and progression of various types of cardiovascular diseases (CVD), including hypertension, diabetes, and heart failure. RECENT ADVANCES: Evidence suggests that a balance between activation of the ACE/Ang II/AT1 receptor axis and the ACE2/Ang-(1-7)/Mas receptor axis is important for the function of the heart, kidney, and autonomic nervous system control of the circulation in the normal healthy state. An imbalance in these opposing pathways toward the ACE/Ang II/AT1 receptor axis is associated with CVD. The key component of this imbalance with respect to neural control of the circulation is the negative interaction between oxidative and NO• mechanisms, which leads to enhanced sympathetic tone and activation in disease conditions such as hypertension and heart failure. CRITICAL ISSUES: The key mechanisms that disrupt normal regulation of Ang II and Ang-(1-7) signaling and promote pathogenesis of CVD at all organ levels remain poorly understood. The reciprocal relation between ACE and ACE2 expression and function suggests they are controlled interdependently at pre- and post-translational levels. Insights from neural studies suggest that an interaction between oxidative and nitrosative pathways may be key. FUTURE DIRECTIONS: The role of redox mechanisms in the control of expression and activity of RAS enzymes and Ang receptors may provide important insight into the function of local tissue RAS in health and disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462736      PMCID: PMC3771546          DOI: 10.1089/ars.2012.4614

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  87 in total

1.  Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7).

Authors:  S Heringer-Walther; T Walther; M C Khosla; R A Santos; M J Campagnole-Santos
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

Review 2.  The brain renin-angiotensin system: location and physiological roles.

Authors:  M J McKinley; A L Albiston; A M Allen; M L Mathai; C N May; R M McAllen; B J Oldfield; F A O Mendelsohn; S Y Chai
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

3.  Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus.

Authors:  M M Gironacci; M Vatta; M Rodriguez-Fermepín; B E Fernández; C Peña
Journal:  Hypertension       Date:  2000-06       Impact factor: 10.190

4.  Renal segmental microvascular responses to ANG II in AT1A receptor null mice.

Authors:  Lisa M Harrison-Bernard; Anthony K Cook; Michael I Oliverio; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2002-11-12

5.  A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.

Authors:  M Donoghue; F Hsieh; E Baronas; K Godbout; M Gosselin; N Stagliano; M Donovan; B Woolf; K Robison; R Jeyaseelan; R E Breitbart; S Acton
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

6.  Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.

Authors:  Yuichiro Ishiyama; Patricia E Gallagher; David B Averill; E Ann Tallant; K Bridget Brosnihan; Carlos M Ferrario
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

Review 7.  The role of ACE2 in cardiovascular physiology.

Authors:  Gavin Y Oudit; Michael A Crackower; Peter H Backx; Josef M Penninger
Journal:  Trends Cardiovasc Med       Date:  2003-04       Impact factor: 6.677

8.  Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.

Authors:  Robson A S Santos; Ana C Simoes e Silva; Christine Maric; Denise M R Silva; Raquel Pillar Machado; Insa de Buhr; Silvia Heringer-Walther; Sergio Veloso B Pinheiro; Myriam Teresa Lopes; Michael Bader; Elizabeth P Mendes; Virgina Soares Lemos; Maria Jose Campagnole-Santos; Heinz-Peter Schultheiss; Robert Speth; Thomas Walther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

9.  Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors.

Authors:  Antonio J Magaldi; Katia R Cesar; Magali de Araújo; Ana C Simões e Silva; Robson A S Santos
Journal:  Pflugers Arch       Date:  2003-10-08       Impact factor: 3.657

10.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

Authors:  I Hamming; W Timens; M L C Bulthuis; A T Lely; G J Navis; H van Goor
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

View more
  17 in total

1.  Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.

Authors:  Xiaowei Zhang; Heng-Jie Cheng; Peng Zhou; Dalane W Kitzman; Carlos M Ferrario; Wei-Min Li; Che Ping Cheng
Journal:  Int J Cardiol       Date:  2017-01-10       Impact factor: 4.164

Review 2.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

Review 3.  Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states.

Authors:  Neeru M Sharma; Kaushik P Patel
Journal:  Expert Opin Ther Targets       Date:  2016-12-02       Impact factor: 6.902

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

5.  ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes.

Authors:  Ji Hyun Jang; Jung Nyeo Chun; Shigeo Godo; Guangyu Wu; Hiroaki Shimokawa; Chun Zi Jin; Ju Hong Jeon; Sung Joon Kim; Zhe Hu Jin; Yin Hua Zhang
Journal:  Basic Res Cardiol       Date:  2015-03-25       Impact factor: 17.165

6.  Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.

Authors:  Jacquie Baker; Anthony V Incognito; Richard J A Wilson; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-07-06       Impact factor: 3.145

7.  The Proatherogenic Effect of Chronic Nitric Oxide Synthesis Inhibition in ApoE-Null Mice Is Dependent on the Presence of PPAR α.

Authors:  Michal Vechoropoulos; Maya Ish-Shalom; Sigal Shaklai; Jessica Sack; Naftali Stern; Karen M Tordjman
Journal:  PPAR Res       Date:  2014-01-22       Impact factor: 4.964

Review 8.  The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders.

Authors:  Man Lung Fung
Journal:  Front Physiol       Date:  2014-09-05       Impact factor: 4.566

9.  Association between arginine catabolism and major depressive disorder: A protocol for the systematic review and meta-analysis of metabolic pathway.

Authors:  Bing Cao; Runze Deng; Dongfang Wang; Li Li; Zhongyu Ren; Lixin Xu; Xiao Gao
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

Review 10.  Sympathetic activation: a potential link between comorbidities and COVID-19.

Authors:  Andrea Porzionato; Aron Emmi; Silvia Barbon; Rafael Boscolo-Berto; Carla Stecco; Elena Stocco; Veronica Macchi; Raffaele De Caro
Journal:  FEBS J       Date:  2020-08-01       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.